Survey of Ophthalmology
Volume 48, Issue 1 , Pages 85-91 , January 2003

The Double Vision Decision

  • Michael S Vaphiades, DO

      Affiliations

    • Corresponding Author InformationReprint address: Michael S. Vaphiades, DO, UAB Department of Ophthalmology, Suite 601, 700 South 18th Street, Birmingham, AL, USA 35233

References 

  1. Al-Din AN, Anderson M, Eeg-Olofsson O. Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia (a review). Acta Neurol Scand. 1994;89:157–163
  2. Anderson NE, Cunningham JM, Posner JB. Autoimmune pathogenesis of paraneoplastic neurological syndromes. Crit Rev Neurobiol. 1987;3:245–299
  3. Bickerstaff ER. Brainstem encephalitis (further observations on a grave syndrome with benign prognosis). Br Med J. 1957;1:1384–1387
  4. Boghen D, Sebag M, Michaud J. Paraneoplastic optic neuritis and encephalomyelitis. Report of a case. Arch Neurol. 1988;45:353–356
  5. Buchwald B, Bufler J, Carpo M, et al.  Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome. Neurology. 2001;56:67–74
  6. Bullens RW, O'Hanlon GM, Goodyear CS, et al.  Anti-GQ1b antibodies and evoked acetylcholine release at mouse motor endplates. Muscle Nerve. 2000;23:1035–1043
  7. Chaudhuri KR, Taylor IK, Niven RM, Abbott RJ. A case of systemic lupus erythematosus presenting as Guillain-Barre syndrome. Br J Rheumatol. 1989;28:440–442
  8. Chiba A, Kusunoki S, Obata H, et al.  Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 1997;16:32–36
  9. Cogen MS, Kline LB, Duvall ER. Bilateral internuclear ophthalmoplegia in systemic lupus erythematosus. J Clin Neuroophthalmol. 1987;7:69–73
  10. Dalos NP, Borel C, Hanley DF. Cardiovascular autonomic dysfunction in Guillain-Barre syndrome. Therapeutic implications of Swan-Ganz monitoring. Arch Neurol. 1988;45:115–117
  11. Evans OB, Lexow SS. Painful ophthalmoplegia in systemic lupus erythematosus. Ann Neurol. 1978;4:584–585
  12. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956;255:57–65
  13. In:  Ropper AH,  Wihdicks EFM,  Truax BT editor. Guillain-Barré Syndrome. Philadelphia: FA Davis; 1991;
  14. Hagen NA, Stevens JC, Michet CJ. Trigeminal sensory neuropathy associated with connective tissue diseases. Neurology. 1990;40:891–896
  15. Hammack JE, Kimmel DW, O'Neill BP, Lennon VA. Paraneoplastic cerebellar degeneration (a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies). Mayo Clin Proc. 1990;65:1423–1431
  16. Hankey GJ. Guillain-Barre syndrome in Western Australia, 1980–1985. Med J Aust. 1987;146:130–133
  17. Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barre syndrome. J Neuroimmunol. 1999;100:74–97
  18. Kashihara K, Yabuki S, Mimori Y. An outbreak of Guillain-Barré syndrome with ophthalmoplegia in Kochi. Shinrigaku Kenkyu. 1987;58:326–329
  19. Kuwabara S, Mori M, Ogawara K, et al.  Intravenous immunoglobulin therapy for Guillain-Barre syndrome with IgG anti-GM1 antibody. Muscle Nerve. 2001;24:54–58
  20. Loffel NB, Rossi LN, Mumenthaler M, et al.  The Landry-Guillain-barre syndrome. Complications, prognosis and natural history in. 1977;123(cases. J Neurol Sci 33):71–79
  21. Luiz JE, Lee AG, Keltner JL, et al.  Paraneoplastic optic neuropathy and auto-antibody production in small-cell carcinoma of the lung. J Neuroophthalmol. 1998;18:178–181
  22. McCarthy N, Giesecke J. Incidence of Guillain-Barre syndrome following infection with Campylobacter jejuni. Am J Epidemiol. 2001;153:610–614
  23. McKhann GM, Cornblath DR, Griffin JW, et al.  Acute motor axonal neuropathy (a frequent cause of acute flaccid paralysis in China). Ann Neurol. 1993;33:333–342
  24. McKhann GM, Griffin JW, Cornblath DR, et al.  Plasmapheresis and Guillain-Barre syndrome (analysis of prognostic factors and the effect of plasmapheresis). Ann Neurol. 1988;23:347–353
  25. Meienberg O, Ryffel E. Supranuclear eye movement disorders in Fishers syndrome of ophthalmoplegia, ataxia, and areflexia. Report of a case and literature review. Arch Neurol. 1983;40:402–405
  26. Mori M, Kuwabara S, Koga M, et al.  IgG anti-GQ1b positive acute ataxia without ophthalmoplegia. J Neurol Neurosurg Psychiat. 1999;67:668–670
  27. Murata Y, Yamaguchi S, Kawakami H, et al.  Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Arch Neurol. 1998;55:33–37
  28. Nagaoka U, Kato T, Kurita K, et al.  Cranial nerve enhancement on three-dimensional MRI in Miller Fisher syndrome. Neurology. 1996;47:1601–1602
  29. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome (clinical and immunological range). J Neurol Neurosurg Psychiatry. 2001;70:50–55
  30. Patja A, Paunio M, Kinnunen E, et al.  Risk of Guillain-Barré syndrome after measles-mumps-rubella vaccination. J Pediatr. 2001;138:250–254
  31. In:  Dyck PJ,  Thomas PK,  Griffin JW, et al. editor. Peripheral Neuropathy. Philadelphia: Saunders; 1993;p. 1437–1497
  32. Plomp JJ, Molenaar PC, O'Hanlon GM, et al.  Miller Fisher anti-GQ1b antibodies (alpha-latrotoxin-like effects on motor end plates). Ann Neurol. 1999;45:189–199
  33. Prestigiacomo CJ, Balmaceda C, Dalmau J. Anti-Ri-associated paraneoplastic opsoclonus-ataxia syndrome in a man with transitional cell carcinoma. Cancer. 2001;91:1423–1428
  34. Adams RD, Victor M. Principles of Neurology. 7th edition. New York: McGraw-Hill; 2001;
  35. Ropper AH. Three patients with Fishers syndrome and normal MRI. Neurology. 1988;38:1630–1631
  36. Ropper AH. Unusual clinical variants and signs in Guillain-Barre syndrome. Arch Neurol. 1986;43:1150–1152
  37. Samantray SK, Johnson SC, Mathai KV, Pulimood BM. Landry-Guillain-Barre-Strohl syndrome. A study of. 1977;302(cases. Med J Aust 2):84–91
  38. Seguardo OG, Kruger H, Mertens HG. Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders. J Neurol. 1986;3:202–208
  39. Soong BW, Lin KP. Correlation of peripheral nerve fiber loss and trinucleotide repeats in Machado-Joseph disease. Can J Neurol Sci. 1998;25:59–63
  40. Subramony SH, Filla A. Autosomal dominant spinocerebellar ataxias ad infinitum?. Neurology. 2001;56:287–289
  41. In:  Lahita RG editors. Systemic Lupus Erythematosus. Neuropsychiatric Disorders In Systemic Lupus Erythematosus. New York: John Wiley and Sons; 1987;p. 593–614
  42. Tanaka H, Yuki N, Hirata K. Trochlear nerve enhancement on three-dimensional magnetic resonance imaging in Fisher syndrome. Am J Ophthalmol. 1998;126:322–324
  43. Truax BT. Autonomic disturbances in the Guillain-Barré syndrome. Semin Neurol. 1984;4:462–468
  44. vd Kruijk RA, Lampe AS, Endtz HP. Bilateral abducens paresis following Campylobacter jejuni enteritis. J Infect. 1992;24:215–216
  45. In:  Miller NR editors. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Baltimore: Williams and Wilkins; 1982;
  46. In:  Newman NJ editors. Walsh and Hoyt's Clinical Neuro-Ophthalmology. 5th ed. Baltimore: Williams & Wilkins; 1998;
  47. Yu Z, Kryzer TJ, Griesmann GE, et al.  CRMP-5 neuronal autoantibody (marker of lung cancer and thymoma-related autoimmunity). Ann Neurol. 2001;49:146–154
  48. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol. 1996;39:668–672
  49. Yuki N, Odaka M, Hirata K. Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody (clinical features). Ophthalmology. 2001;108:196–200
  50. Yuki N, Sato S, Tsuji S, et al.  An immunologic abnormality common to Bickerstaffs brain stem encephalitis and Fishers syndrome. J Neurol Sci. 1993;118:83–87
  51. Yuki N, Sato S, Tsuji S, et al.  Frequent presence of anti-GQ1b antibody in Fishers syndrome. Neurology. 1993;43:414–417
  52. Zasorin NL, Yee RD, Baloh RW. Eye-movement abnormalities in ophthalmoplegia, ataxia, and areflexia (Fishers syndrome). Arch Ophthalmol. 1985;103:55–58

☆ This work was supported in part by an unrestricted grant from the Research to Prevent Blindness, Inc. New York, NY. The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(02)00399-5

Survey of Ophthalmology
Volume 48, Issue 1 , Pages 85-91 , January 2003

Article Tools

* Image Usage & Resolution